ejection-fraction

Documents about ejection-fraction

• Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF)#910586ClinicalTrials.gov
• Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction#837534ClinicalTrials.gov
• Impact of Perioperative Levosimendan on Patients Undergoing Cardiac Surgery With Low Ejection Fraction#852871ClinicalTrials.gov
• Neuromodulation to Treat Patients With Heart Failure With Preserved Ejection Fraction#967750ClinicalTrials.gov
• Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction#873968ClinicalTrials.gov
• Copenhagen Heart Failure With Preserved Ejection Fraction#911926ClinicalTrials.gov
• Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients#810878ClinicalTrials.gov
• UK Heart Failure With Preserved Ejection Fraction#887006ClinicalTrials.gov
• Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction#981305ClinicalTrials.gov
• Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction#624958HAL (France)
• Iron Deficiency in Patients With Heart Failure and Reduced and Mildly Reduced Ejection Fraction#842489ClinicalTrials.gov
• Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction#267990ClinicalTrials.gov
• Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study#467539ClinicalTrials.gov
• The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction#902984ClinicalTrials.gov
• Classification of Heart Failure With Preserved Ejection Fraction#836194ClinicalTrials.gov
• Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial#875435ClinicalTrials.gov
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction#894515ClinicalTrials.gov
• Efficacy of Remote Monitoring of Patients With Heart Failure and Reduced Ejection Fraction by Using Caaring® Software#883765ClinicalTrials.gov
• AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment#886243ClinicalTrials.gov
• Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension#405231ClinicalTrials.gov
• Extended IASD Investigation: REDUCE LAP-HF IV#802914ClinicalTrials.gov
• Ketones in Heart Failure With Reduced Ejection Fraction#831898ClinicalTrials.gov
• Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection Fraction#832013ClinicalTrials.gov
• Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication#830316ClinicalTrials.gov
• Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction#802030ClinicalTrials.gov
• The Sarcopenia Study#230320ClinicalTrials.gov
• HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction#865519ClinicalTrials.gov
• Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction#895708ClinicalTrials.gov
• Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction#834484ClinicalTrials.gov
• Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.#879935ClinicalTrials.gov
• Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction#906534ClinicalTrials.gov
• Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF#827045ClinicalTrials.gov
• Prediction of the Development of Heart Failure With Preserved Ejection Fraction#838297ClinicalTrials.gov
• MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction#992806ClinicalTrials.gov
• PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction#993816ClinicalTrials.gov
• Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.#905822ClinicalTrials.gov
• DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY#803920ClinicalTrials.gov
• Build fair machine learning models to predict adverse outcomes for heart failure patients with preserved ejection fraction and with reduced ejection fraction.#360659NCBI PubMed Central
• Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial Dysfunction#808056ClinicalTrials.gov
• Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients#824879ClinicalTrials.gov
• Speckle Tracking Imaging in Patients With Low Ejection Fraction Aortic Stenosis (SPArKLE-AS)#835455ClinicalTrials.gov
• A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction#840652ClinicalTrials.gov
• Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation#981956ClinicalTrials.gov
• A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction#1007719ClinicalTrials.gov
• Global Strain and Mechanical Dispersion May Predict Death and Ventricular Arrhythmias Better Than Ejection Fraction#874429ClinicalTrials.gov
• Heart Failure With Preserved Ejection Fraction: Evaluation and Recognition by CMR#982490ClinicalTrials.gov
• Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction#442054ClinicalTrials.gov
• Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction#901310ClinicalTrials.gov
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction#991910ClinicalTrials.gov
• Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients#121515ClinicalTrials.gov